pharmaceutical formulation – Page 4

Investigating Core Erosion in Extended Release Tablets During Stability Storage

Investigating Core Erosion in Extended Release Tablets During Stability Storage Investigating Core Erosion in Extended Release Tablets During Stability Storage Introduction: In the realm of pharmaceutical development, extended release (ER)…

Difficulty in evaluating the impact of excipient changes on capsule stability.

Difficulty in evaluating the impact of excipient changes on capsule stability. Difficulty in Evaluating the Impact of Excipient Changes on Capsule Stability Introduction: In the pharmaceutical industry, the stability of…

Difficulty in ensuring consistent gelatin solution viscosity during production.

Difficulty in ensuring consistent gelatin solution viscosity during production. Difficulty in Ensuring Consistent Gelatin Solution Viscosity During Production Introduction: In the realm of pharmaceutical manufacturing, ensuring the consistent viscosity of…

Difficulty in ensuring compliance with bioequivalence requirements for capsules.

Difficulty in ensuring compliance with bioequivalence requirements for capsules. Difficulty in ensuring compliance with bioequivalence requirements for capsules. Introduction: In the pharmaceutical industry, ensuring that generic formulations are bioequivalent to…

Validating Coating Thickness Consistency Across Batch Sizes

Validating Coating Thickness Consistency Across Batch Sizes Validating Coating Thickness Consistency Across Batch Sizes Introduction: The pharmaceutical industry places significant emphasis on the quality and consistency of solid dosage forms,…

Problems with achieving consistent shell thickness for multi-particulate capsules.

Problems with achieving consistent shell thickness for multi-particulate capsules. Problems with achieving consistent shell thickness for multi-particulate capsules. Introduction: In the pharmaceutical industry, the production of multi-particulate capsules has become…

Problems with predicting the stability of capsules containing sensitive APIs.

Problems with predicting the stability of capsules containing sensitive APIs. Problems with Predicting the Stability of Capsules Containing Sensitive APIs Introduction: In the pharmaceutical industry, ensuring the stability of drug…

Poor adhesion of tamper-evident seals to capsule containers.

Poor adhesion of tamper-evident seals to capsule containers. Poor adhesion of tamper-evident seals to capsule containers. Introduction: The pharmaceutical industry places a high premium on ensuring the safety and integrity…

Problems with maintaining consistent capsule hardness.

Problems with maintaining consistent capsule hardness. Problems with Maintaining Consistent Capsule Hardness Introduction: Capsules, whether hard or soft gelatin, are among the most prevalent forms of solid oral dosage forms…

Difficulty in assessing stability of capsules containing hygroscopic excipients.

Difficulty in assessing stability of capsules containing hygroscopic excipients. Difficulty in Assessing Stability of Capsules Containing Hygroscopic Excipients Introduction: In the pharmaceutical industry, the stability of drug formulations is paramount…

Identifying Causes of Poor Disintegration in Controlled Release Tablets

Identifying Causes of Poor Disintegration in Controlled Release Tablets Identifying Causes of Poor Disintegration in Controlled Release Tablets Introduction: In the realm of pharmaceuticals, controlled release tablets have become a…

Ensuring Consistency in API Release Profiles for Controlled Release Tablets

Ensuring Consistency in API Release Profiles for Controlled Release Tablets Ensuring Consistency in API Release Profiles for Controlled Release Tablets Introduction: In the world of pharmaceuticals, controlled release tablets play…